boston745
3 days ago
mrinvestorpro
9m
@BroadOne no it means a sale or partnership. They have $15 per share in cash. Not including their patents, technology or clients. They sell for $15+ you triple your money. Get a partner and u could get 10x your money on a run with that tiny float.
BroadOne = PitK17. Guess he decided to change his avatar for some reason. This MrInvestorPro makes good points except they do not have $15 per share in cash unfortunately. ~$6m in Cash end of Q1 with a burn of about $2.8m a quarter means they have about $6m cash at the beginning of Q3 after the funds raised in Q2 offerings. Thus $6m cash and OS of 750k thats $8 per share with a current stock price of $5.07 or so. Stockholders equity is about $13.00 per share right now. Stockholders equity does not factor in the value of Sintx IP. Hell its accumulated deficit is worth $300 per share right now.
I dont think they are looking to sell the entire company but could sell off an asset. Id rather a partnership or sell off Armor to NP Aerospace with licensing revenue. Regardless you can bet the hedge funds that are trying to acquire Sintx through hostile means will look to sabotage any such deals.
https://stocktwits.com/mrinvestorpro/message/580096417
========================================
Section 2 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
4 days ago
The increase in the number of shares of authorized but unissued and unreserved Common Stock will have an “anti-takeover effect” by permitting the issuance of shares to purchasers who might oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of our Charter.
Another anti-takeover measure, issuing more shares to holders of common stock that would oppose a hostile takeover by the conspiracy of funds mentioned in a previous post of mine. As you can see in the next section of this post, Anson and its family of funds often target companies with valuable assets, like Sintx, to try to acquire in a hostile fashion. Usually they go for board seats but they can do low ball offers. FYI: This language was not present in the previous RS.
https://www.sec.gov/Archives/edgar/data/1269026/000149315224014753/formdefn14a.htm pg 9.
========================================
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. IP thats destined to take over the ortho industry according to one study linked at the bottom of this post.
Their playbook is simple: they find a promising company like Nano that has attracted significant investment, furtively acquire a large position, and then seek to dismantle the company and distribute its cash for Defendants’ own benefit.
https://www.sec.gov/Archives/edgar/data/1491072/000119312523131774/d264274dex993.htm
So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed. A work in progress.
Transitive Property:
In 2003, Zimmer acquired a materials company for $232m with $108m of it upfront and the remaining $124m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabecular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee. That said, Trabecular metal cannot be used as a coating or imbued in materials like silicon nitride can to bring those materials its beneficial enhancements. Thus its market potential in the ortho/dental markets was smaller.
Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m
Accumulated Deficit and Tax Write-off
Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Also, acquiring Sintx for that amount would increase goodwill which is an asset the acquiring company can depreciate and thus provide additional tax benefit as well as increase its assets.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
In Summary, you can see that Sintx has extremely valuable IP that can be used in markets that are cumulatively in the hundreds of billions in size. That is why Anson and the other family of funds its connected to would want to get their hands onto that IP. Like Nano, it looks like this conspiracy of funds was getting ready to make a move before I exposed them with three of the funds accumulating a position this year. However recent offerings by management seems to have helped in diluting their positions to prevent a similar situation to Nano as shown in the first of these three posts.
Because Sonny has employed several methods of protection to protect Sintx IP from hostile entities, their only option to get the IP is hope they can drive Sintx into bankruptcy as Sonny has setup crown jewels defense in the event this group attempts a hostile takeover. As Sintx has no debt, Sonny and then board cannot be forced into selling the IP to a particular entity. Upside to Sintx not having loans and likely a big reason it has not obtained one so since Hercules loan in 2014.
4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
https://www.sec.gov/Archives/edgar/data/1269026/000107997324000472/0001079973-24-000472-index.htm
Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.
(2) Based on 51,080,139 shares of Common Stock outstanding as reported in the Issuer’s filings with the Securities and Exchange Commission.
Once this offering completed, L1 stake in Sintx became 3.6%.
This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position (Poison Pill type offering?). Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds as well as raising needed funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. This has likely prompted the recent new of Sintx exploring strategic opportunities.
Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
=======================================
Section 3 - Here are all the anti-takeover provisions employed at Sintx.
1. Poison pill aka Shareholder Rights Plan
2. Staggered Board
3. Shark Repellant - requiring supermajority vote
4. Golden Parachute for management
5. Crown Jewel Defense - CTL has first rights to acquire Sintx IP.
6. CTL is setup as a White Knight via its first rights to acquire Sintx IP.
7. If Sintx sold its main IP to CTL thats effectively scorched earth as Sintx has little value, in comparison, without its patent portfolio. Sintx would still have TA&T & Sintx Armor for value in the event it had to sell its core Si3n4 IP to CTL, even if for a short time.
========================================
Section 4- A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
========================================
Section 5 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
4 days ago
Sonny needs to do something to increase valuation, and keep it elevated, as SINT current market valuation is a mere $3.7m. If the OS jumps to 1.4m thats around $2.8 price per share to maintain that $4m valuation. $5.7 equates to $8m valuation at 1.4m OS. Despite multiple pieces of good news nothing seems to allow valuation increase over $4m for long. Even an up to $8m aerospace contract over a 10 year period didnt help increase valuation. Of course those shorting and distorting here arent going to allow the price to increase for long.
$4m valuation is over a 50% discount from stockholders equity.
Valued at potentially as much as $8 million over the life of the agreement, the LTA represents the single largest customer agreement to date for SINTX. The LTA incorporates a significant commitment from SINTX to collaborate with their customer on reducing costs, improving efficiencies, and implementing productivity programs. The LTA extends to the end of 2034 with a customer option to renew for an additional 10-year period.
https://ir.sintx.com/news-events/press-releases/detail/223/sintx-technologies-enters-into-a-second-long-term-supply
Exposing Market Manipulation tactics:
https://fastercapital.com/content/Market-Manipulation--Exposing-the-Tactics-of-Stock-Bashers.html#Common-Tactics-Employed-by-Stock-Bashers
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Section 2 - A conspiracy of shorting and distorting funds and their wolfpack.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
5 days ago
This is something Sonny has done for shareholder, or true stakeholders, of Sintx.
Unless otherwise indicated, the information in this prospectus supplement, including the number of shares outstanding after this offering, does not reflect:
? the effect of the “full-ratchet” anti-dilution adjustment of the conversion price of our outstanding Series B Convertible Preferred Stock and the exercise price of our outstanding October 2022 warrants.
As the stock price decreases so too does the conversion prices of these Series B preferred and October 2022 warrants. I have the latter as i participated in the 2022 shareholder rights offering. Current conversion of Series B from '20 and Oct '22 warrants is $4.2. Are those shorting and distorting here going to lower my conversion price further? Either way i win. Price goes up i can make money. Price goes down it reduces the cost of conversion (cost basis) for when this eventually goes waaaayyy up (assuming Sonny prevails).
The October 2022 warrants are exercisable at an exercise price of $4.20 per share. The Series B convertible preferred stock and October 2022 warrants contain full-ratchet anti-dilution provisions which, subject to limited exceptions, would reduce the conversion price of the Series B preferred stock (and increase the number of shares issuable under the Series B preferred stock) and reduce the exercise price of the October 2022 warrants in the event that we in the future issue common stock, or securities convertible into or exercisable to purchase common stock, at a price per share lower than the conversion price or exercise price then in effect. Depending upon how such provisions are interpreted, the alternative cashless exercise provision contained in the Class C Warrants and Class D Warrants could potentially result in a significant reduction in the conversion or exercise price of the Series B convertible preferred stock and October 2022 warrants.
My preferred shares from the 2022 rights offering are essentially worthless, outside of loss harvesting, right now because of the Reverse splits. However its possible that in future rights offerings i'd be allowed to exchange current preferred for new offering units at much more favorable conversion price. This was done for holders of units from before Sintx went public. Investors like Sonny were able to exchange their old preferred for new units.
This goes against the narrative management doesnt care about its stakeholding (true long) shareholders and hasnt done anything to protect their investment while Sonny battles hostile funds attacking SINT.
In regards to the CEO's bonuses, Sonny deserves them for the sheer value hes created to Sintx IP over his time as CEO. Sintx went from being able to potentially sell products in a $64 billion dollar ortho implant and $5 billion dental industry , to now having potential products that could participate in industries that exceed $300 billion in size; this being a major reason this family of funds would be trying to seize Sintx through any means it can. So yes $50k bonuses is cheap for that level of accomplishment. He deserves larger bonuses but Sintx cannot afford that until he actually starts commercializing some of those products. When he, or his successor does, then shareholders might finally start to get a return on their investments over the years. Until then this remains insanely cheap valued at only $3.9m while being risky due to those hostile funds.
Quote Source:
https://www.sec.gov/Archives/edgar/data/1269026/000149315224026958/form424b5.htm
========================================
Section 2 - Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
========================================
Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
5 days ago
This is essentially how the wolfpack operates around offerings. They naked short before the offering via one fund and then one or more of the other funds buy the offering and they use those shares to cover the the naked short position of funds not participating in the offering. At first i thought this how how they circumvent SEC rules that prevent a fund preshorting an offering like this. However it seems that if funds collectively own more than 10% of the offering/outstanding shares, then they are illegally pre-naked shorting offerings in addition to trading on inside information. If they naked shorted last week, id think they'll be wanting to get people to sell their shares to cover those naked short positions if Sonny delays releasing new shares to market. So watch for posts that over-exaggerate managements lifestyle, pay, or anything "negative".
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
These companies -- there were 13 of them, all pretty small -- raised money through what the SEC calls "confidentially marketed public offerings." A company would engage an investment bank, which would call up potential investors and ask if they wanted to buy shares in the company. The bank would do this before the company publicly announced the offering, and would "wall-cross" the potential investors, making them agree to keep the information about the offering secret until it was announced publicly.
So here's a predictable stock-market pattern and an easy way to exploit it: If a company calls you up to ask you to invest in its upcoming public offering, you should (1) say yes, (2) sell the company's stock short before the public announcement, and then (3) buy the stock back in the public offering, generally at a 10+ percent discount, a few days later.
This is of course not legal advice! It is a great trade, but it is also double super illegal, insofar as:
There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering, 5 and
There is a general, and much more important, rule against trading on purloined material nonpublic information, and this is that.
trading in breach of that agreement, you are clearly violating not just the contract, but also insider trading laws, which make it illegal to trade "in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security."
But, you know, who will check?
Some of the funds would get wall-crossed, and then they'd tip each other and trade in the other funds to try to obscure what was going on:
When they were successful in obtaining such information, Fishoff shorted the issuer’s stock in advance of the offerings, directed trading by Chernin and Costantin in those instances when he did not place the trades on his own, and tipped Petrello, who then also shorted the stock through Brielle and Oceanview.
In many instances, the Fishoff-controlled entities for which Chernin and Costantin were fronting also participated in the offering, with the stock going to Featherwood’s account and often being used to cover the short sales.
This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?
By cheating on their wall-cross agreements and shorting the stock, these guys had the effect of driving down the stock price, which probably reduced the price in the offering. These companies probably got less money for their stock because their nonpublic information was (allegedly) used against them.
Though you could have a more cynical view of this sort of thing. A company needs to sell stock, but worries that announcing a public offering will drive down its stock price and not produce any takers. So it calls some investors up privately and tells them it's doing a deal. Those investors agree to invest in the deal, but before the deal is announced they lay off their risk by shorting the company's stock. Then the deal is announced and the investors buy shares from the company to (illegally) cover their shorts. The investors get their 10 percent, or whatever, discount to the market price as a commission; their real function is not to invest in the deal but to intermediate between the company (which can't sell stock without a publicly disclosed offering) and the unsuspecting public (which buys from the "investors" before the public disclosure). The wall-cross agreement creates deniability for the company. No one's stealing from the company; they're helping the company get a deal done that would otherwise be much harder to achieve. The victims are the public who buy from the insider traders at the inflated, pre-announcement price.
There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering, these funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).
You short 16 million, knowing once the offering price is announced, the stock will take a hit. Voila, in 24 to 48 hours you just made 1.6 million by buying back at .15 +
Fund A would be the one that bought the offering, in this case Lind Group. Funds B, etc.. (theres like 9 funds identified so far) would be the ones naked shorting like described here by Joev2. For which i replied:
Its the hfunds that made the $1.6m you describe. Also they NAKED shorted on news of the R&D contract with the army, thus they NAKED shorted from .25-.50 range making alot more than the $1.6m you mentioned. If every .1 represents $1.6m profit then if they have an average Naked short position of .35 then that translates to $3.2m in 24 to 48 hours. Essentially funding the offering in 1-2 day period.
They announced the news on Jan 30th when these funds pre-naked shorted the offering and the offering closed on Feb 2nd. This is exactly the scenario depicted in the above and its accomplished by trading inside information and using multiple hedge funds to bypass the sec rule that prevents funds from shorting before an offering they participate in. Then these funds can wash trade the stock price lower trading back and forth between each other, to make even more money shorting the stock. You can see how many naked shares that remained uncovered by the 2nd of Feb.
20240202|829392604|SINT|5,939,951|SINTX TECHNOLOGIES INC COM COM|0.15
Something posted by XenaLives years ago and it seems to correlate with all this, especially post split as theyve been walking the price down.
The 10000 can be wash traded back and forth freely between colluding computers. Tons of money is made so they can now walk the stock down even lower because risk has been reduced.
Instead of thinking of this as simply colluding computers, think of it as Fund A & Fund B colluding to trade back n forth to walk the price down. Anson and the other funds in the family are well known for this sort of behavior and they couldnt have been more obvious about it after the Feb 2023 offering.
Quote Sources:
https://web.archive.org/web/20190331202955/https://www.bloomberg.com/opinion/articles/2015-06-03/insider-traders-made-some-easy-money-on-stock-offerings
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173751723
https://investorshub.advfn.com/boards/replies.aspx?msg=173751723
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139777542
boston745
6 days ago
Correct me if im wrong, but isnt the offering is an ATM, so the shares can be distributed on an as needed basis overtime? They dont need to lower the price to generate interest necessarily, very undervalued as it is at only $4m marketcap (~750k x $5.3) which is less than stockholder equity. Actually they need news to help support the stockprice when they distribute especially if the goal is to dilute the conspiracy of funds.
As always Joe, your post is angled as a basher post like youre part of that wolfpack.
he alleged target was publicly traded Catalyst subsidiary Callidus Capital Corp., claims the lawsuit, which dubs the Anson, West Face and several associated and unrelated individuals as “Wolfpack Conspirators.”
https://financialpost.com/news/fp-street/catalyst-capital-files-450-million-lawsuit-accusing-anson-funds-west-face-of-short-selling-conspiracy
========================================
Section 2 - List of Funds Connected to this Wolfpack of Funds
The following will show there has in fact been a conspiracy of funds, shorting and distorting SINT & Sintx for the past 9 years. My next post will give some insight into how this family of funds might operate. A third post will show that they target vulnerable but promising companies with valuable assets they can secure significant profits from, just how valuable Sintx IP could be, and methods used to defend Sintx from this conspiracy of funds.
Its worth noting that 3 of the family of funds appear to be accumulating a position, just like what was done to Nano in its lawsuit against this conspiracy of funds. Which means they could be getting ready to make their move. Look how it accumulated its position in Nano and then realize three of its family of hedge funds is currently accumulating positions: Anson Funds Management LP, L1 Capital Global Opportunities Master Fund, Ltd. , Lind Global Fund II LP .
https://i.imgur.com/gRnIWov.jpeg
Conspiracy of Funds
First off lets establish the conspiracy of funds working together. Fortunately, in another unrelated lawsuit, the list has been provided:
Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.
List of potential investors the Plaintiff was referencing. All the funds that seem to be connected are in red.
List named the following:
Anson Funds Management LP and its affiliates
Ayrton Capital, Altos Opportunity Fund and their
affiliates
Crede Capital Group, Acquitas Capital and its affiliates
CVI Investment, Heights Management, SIG and their
affiliates
Connective Capital and its affiliates
Empery Asset Management and its affiliates
Intracoastal Capital LP and its affiliates
Hudson Bay Capital Management and its affiliates
Ionic Venture LLC and its affiliates
Lind Partners and its affiliates
Li Capital Global Opportunities Master Fund and their
affiliates
Sabby Management LLC and its affiliates
https://images.law.com/contrib/content/uploads/documents/404/140289/51-2023-08-31-043-Order-Denying-SJMotion.pdf
History of those Funds stake in AMDA/SINT since 2015
List of Funds that have had stakes in AMDA/SINT at one time or another. The first three listed could be accumulating positions in SINT like what was done to NANO. These three funds are connected.
4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
https://www.sec.gov/Archives/edgar/data/1269026/000107997324000472/0001079973-24-000472-index.htm
2024-05-14 13F Anson Funds Management LP 959,297 47
https://fintel.io/so/us/sint
2/07/24 Lind Global Fund II LP
https://www.sec.gov/Archives/edgar/data/1269026/000092963824000396/0000929638-24-000396-index.htm
2/16/2023 INTRACOASTAL CAPITAL, LLC
https://www.sec.gov/Archives/edgar/data/1269026/000121390023012455/0001213900-23-012455-index.htm
2/14/2023 Lind Global Fund II LP
https://www.sec.gov/Archives/edgar/data/1269026/000092963823000614/0000929638-23-000614-index.htm
05/18/2018 CVI Investments, Inc.
https://www.sec.gov/Archives/edgar/data/1269026/000110465918034362/0001104659-18-034362-index.htm
01/19/2017 SABBY MANAGEMENT, LLC
https://www.sec.gov/Archives/edgar/data/1269026/000153561017000068/0001535610-17-000068-index.htm
07/14/2016 ALPHA CAPITAL ANSTALT
https://www.sec.gov/Archives/edgar/data/1269026/000121390016014963/0001213900-16-014963-index.htm
9/14/2015 Frigate Ventures LP = Anson Group
This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Frigate Ventures LP (d/b/a Anson Group), a Texas limited partnership (“Frigate”), Admiralty Advisors LLC, a Texas limited liability company (“Admiralty”), Mr. Bruce R. Winson, the principal of Frigate and Admiralty, M5V Advisors Inc. (d/b/a Anson Group Canada), an Ontario, Canada corporation (“M5V”), Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V, relating to Common Stock, $.01 par value (the “Common Stock”), of Amedica Corporation, a Delaware corporation (the “Issuer”).
https://www.sec.gov/Archives/edgar/data/1269026/000119312515319457/0001193125-15-319457-index.htm
Hudson Bay Capital Management LP 2,789,867 2.16 870,438 Sep 30, 2015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=118775462
XenaLives connecting CVI to ALPHA CAPITAL ANSTALT
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143618825
Lawsuit Sources:
https://www.sec.gov/Archives/edgar/data/1491072/000119312523131774/d264274dex993.htm
https://images.law.com/contrib/content/uploads/documents/404/140289/51-2023-08-31-043-Order-Denying-SJMotion.pdf
This case connects additional funds to Anson that have not had a stake in SINT in the past like Empery Asset Management.
https://casetext.com/case/augenbaum-v-anson-invs-master-fund-8
========================================
Section 3 - A conspiracy of shorting and distorting.
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
joev2
6 days ago
Re Bal's latest: looking at pre-market volume of 14, along with a somewhat stagnant trading pattern since the announcement, I'm guessing once again, few are willing to support at this price, Bal's all too familiar routine....but...time is ticking! I fully expect another announcement shortly, along with a nice price drop, in order to lure them in. He may first do a repeat of the past offer (in case no one really heard lol), but yeah, this is the way he'll go. Actual price when they're able to get enough cash? Under 4....My opinion of course.
Remember folks: if management doesn't see it as investment-worthy, why should you?
boston745
6 days ago
if the 24/7 clown is predicting war and promoting fake products. You can be 100% sure he is wrong. He has never been right about anything. He is a useful idiot
Lets see, i said that Sintx was getting ready to sell itself and it sold part of itself. That part was right. I said Zimmer was its strategic partner, that was right too. I even said Zimmer wanted to acquire Sintx...that was at least true at one time if not still true. I said there was a conspiracy here and sure enough there has been a short and distort conspiracy manipulating the stock for the past 9 years. While i havent proven it, there is even evidence to suggest that conspiracy of funds was trying to take over Sintx through hostile means as they have done this in regards to other companies as ive claimed before. The CEO of Sintx has been deploying multiple methods to prevent hostile takeovers, and the IP is very valuable...something i knew/said to be true back in 2015 before i understood much about the tech.
I predicted Pernix bankruptcy, 2 years later it went BK. I said EM radiation was causing Teslas to go out of control well before there was much evidence to back that claim, thats true. I said Tesla was a scam and sure enough its being investigated for such actions.
Something i have predicted that has not come true...yet, is a global depression. Course global war could help keep that from happening. Multiple predictions have come to pass but few come when i think they will.
I mostly proved that 911 happened so the US had legal grounds to leave the 1972 Anti-ballistic treaty so SpaceX could be born (began the same month US officially left the treaty), and launch Brilliant Pebbles/Eyes into Orbit. The US was about to violate the treaty with the programs Bush Jr was pushing had 911 not occurred. I even found proof that flying saucers are not only real, but are in fact manmade. First invented in the 1930s and further developed by the Nazi's when they seized Viktor Schauberger.
TA, you are part of that short and distort conspiracy, directly or indirectly, and you show it with every lie you post. Odd out of all of the accounts, you rarely speak truth. Least the others that bash Sintx intermix truth in their posts. Useful idiot might be the only thing true in what you said.
========================================
Section 2 - Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
========================================
Section 3 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 4 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
7 days ago
I dont see red nor blue i see purple. This isnt a political debate, its looking at the signs. Arms buildup means war. That in itself doesnt have anything to do with Trump other than his policies during his last administration opened that up as did his US first policies. However Trump being president means the US is far more likely to get into war because people would rather have a leader they see as strong, which the recent "attempt on his life" is being spun to increase that image, than frail. Recent debate was spun to to make Biden look weaker.
I laid out facts for you in my last post and you ignored them. Trump intends on removing illegal and deploying the military within the US, including camps to house those illegals. Those are all Hitler like policies and deploying military into US cities sets up dangerous precedents/possibilities.
The Supreme court just set it up for future presidents to be allowed to pursue illegal actions on behalf of the country without any fear of legal consequences. That allows for dictatorial behaviors by any future President and Trumps definitely the type to utilize these as its well known his public persona is an admirer of Hitler.
Theres been war somewhere in the world during every presidency. US is not active in Ukraine nor in Israel. We are simply sending aid. When i said Trump = War, i mean US involved war. I see WW3 as more likely under Trump than Biden certainly, but i could see a war within with Trump return to presidency and Civil War if Biden was re-elected. All that is good for Sintx Armor and greater need for ortho implants, wound care, anti-infective products, etc... which is all good for Sintx.
Its also estimated that China will take Taiwan during the next presidency.
========================================
Section 2 - Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
boston745
7 days ago
To carry out a deportation operation designed to remove more than 11 million people from the country, Trump told me, he would be willing to build migrant detention camps and deploy the U.S. military, both at the border and inland.
He would gut the U.S. civil service, deploy the National Guard to American cities as he sees fit
Thats more of a war within than outside but i expect China to take Taiwan which the US has been preparing for since Trumps first administration. Trump means war and thats good for Sintx Armor and its partner NP Aerospace! Despite the emphasis that doesnt thrill me at all nor does Hitler 2.0 indicated in that article.
In a historic announcement, in May 2020, TSMC shared its plans to invest $12B in Phoenix, Arizona
https://time.com/6972021/donald-trump-2024-election-interview/
The world wasn’t ready for Trump in 2016. It’s not making that mistake this time.
America’s NATO allies are ramping up weapons production, consulting Donald Trump’s advisers and holding secret meetings with each other to feverishly lay the groundwork for his return.
https://www.politico.com/news/2024/07/07/nato-prepare-trump-2024-00165522
========================================
Section 2 - Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
========================================
Section 3 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
boston745
1 week ago
ANY small bump or sign after a potential run is quashed by Dipwad Sonny….. why is that?????
I'd argue that the hedge funds knew the filing was coming and thats why there was sudden uptick in basher posts on cafepharma and here. Likely building up the naked shorts before offering as was done all of the 2023 into 2024 offerings.
https://stocktwits.com/NoneYaBiz61/message/579451246
pumps sintx in Zimmer forums that Sintx is about to or in the middle of diluting shareholders via offerings and or reverse splits
As my posts were in response to these posts on cafepharma, its actually the opposite. That bashers increase posting before offerings and thus i respond. This shows they have access to inside information. Now if there has been an increase in naked shorts this past week then we'll know for sure as thats how the conspiracy of funds operate with their outside help...all part of their "wolfpack".
The alleged target was publicly traded Catalyst subsidiary Callidus Capital Corp., claims the lawsuit, which dubs the Anson, West Face and several associated and unrelated individuals as “Wolfpack Conspirators.”
https://financialpost.com/news/fp-street/catalyst-capital-files-450-million-lawsuit-accusing-anson-funds-west-face-of-short-selling-conspiracy
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 4 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
1 week ago
3 Colorado poultry workers test presumptively positive for bird flu
Three poultry workers from a farm in northeast Colorado are suspected to have contracted bird flu, state and federal health officials announced Friday.
The three tested presumptively positive for H5N1, also known as avian influenza, while working at a "commercial egg layer operation," the Colorado Department of Public Health and Environment said in a statement.
They were culling poultry at the farm when they showed mild symptoms, including pink eye and common respiratory infections, the agency said. None required hospitalization.
Specimens have been sent to the U.S. Centers for Disease Control and Prevention for confirmatory testing.
The CDC said that the three worked "at a poultry facility experiencing an outbreak of the H5N1 virus that is circulating in wild birds and has been causing multistate outbreaks in dairy cows and poultry."
There have been four confirmed human cases of bird flu in the U.S. since March, all in farmworkers, with two in Michigan, one in Texas and one in Colorado, the CDC said.
https://www.cbsnews.com/news/3-colorado-poultry-workers-test-presumptively-positive-bird-flu-h5n1/
========================================
Section 2 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Section 3 - Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
========================================
Section 4 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
boston745
1 week ago
I thought you said Zimmer Biomet wasnt their femoral head strategic partner? That companies like Zimmer just donate their IP for other companies studies just because? Or were you gaslighting me back then?
Proof Zimmer Biomet is one of Sintx strategic partners:
Sintx 2016 10k
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
This quote indicates the results of testing of their femoral head with a strategic partner will be released in 2017.
Those results were released testing Sintx Femoral head against Biomet's E1 liners. Thus Zimmer Biomet, or any of its subsidiaries, is Sintx strategic partner in this testing.
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
What are strategic alliances?
Strategic alliances, also known as strategic partnerships, are long-term, multi-department commitments with clearly defined goals for both companies. They differ from acquisitions and joint ventures because the companies remain separate entities (like how Starbucks and Target work together, within their own boundaries). However, strategic alliances have been known to lay the groundwork for acquisitions. But more on that later.
Quote Sources:
2016 10-k pg 13: https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm
2017 results: https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
https://web.archive.org/web/20240408152758/https://sintx.com/wp-content/uploads/2021/03/Investor-Call-Transcript-033021.pdf
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
https://insider.crossbeam.com/resources/strategic-alliance-definition-types-examples
boston745
1 week ago
You understand that what im saying is investors can get a return on investment here if Sonny successfully defends Sintx from the conspiracy of hedge funds trying to steal the IP. Not to mention they could see greater return than if that conspiracy of funds won. Especially if he sells the core IP to Zimmer Biomet in the end. This falls under the debate of Stakeholder vs shareholder and how CEOs have a greater duty to their stakeholders than shareholders (alot of shareholders are stakeholders but not all).
Until then long investors can keep watching, buying any shareholder rights offerings to help protect their investment, and swing trade until Sonny wins as theres continued risk as long as those funds are trying to steal the tech. Just requires patience. The IP is destined for greatness and will help improve alot of lives! I know thats a rhetorical statement but according to the study in Section 3 of this post, it actually is destined for greatness.
The reason they can see a return is the sheer value Sonny has created with the companies IP that just needs to be commercialized with some of the partners already in place.
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
https://web.archive.org/web/20240408152758/https://sintx.com/wp-content/uploads/2021/03/Investor-Call-Transcript-033021.pdf
========================================
Section 2 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
joev2
1 week ago
As far as keeping the Anson types at bay, I know others have done a much better job as evidenced by less dilution and reversing. I don't know enough about how they do it. I do know they're not all the same and it's quite obvious by the numerous solicitations Mick received, that all are not necessarily interested in the products offered, just the green they can receive by ripping them and the shareholders off.
As for the spinach comparison, investors first and foremost, generally want to see a return on their 'investment', not one loss after the other. I'd rather be part of a spinach campaign that benefits me once in a while, than a "win, win mega millions for everyone and blessings for all to boot" campaign, when in reality, the only winners remain the gamers and the elite. And feel free to believe I consider management 'elite' in this case, because I do, since there are no negative repercussions whatsoever to them, for the stupid and ridiculous way they have run this thing. Evidence? The nonstop negative stock performance, going on for years, REALLY does tell the story. As mentioned in other posts, I've never personally seen a legitimate management team remain, under such a scenario. With Sint, you basically have an autocrat doing everything which is another red flag: no accountability to anyone: never an open forum with the investment community: false and misleading news releases.
And no I'm not that dumb, but I do question my sanity going back and forth with you. In case you hadn't noticed (but I'm sure you did), I ended the statement you quoted with the part you chose not to. Thus I clarified something even the dumbest amongst us could understand i.e. a stock ALWAYS down, is not worth the effort to search out further.
Only a negative direction continually, tells enough of the story to me....
boston745
1 week ago
Over on ST in typical basher fashion, tech01 uses a mix of truth and deception. More on the short and distort campaign being waged against Sintx in section 3 of this post.
SINTX Armor is a joke... they announced they were expecting revenue in 2022, and then again in 2023.
Then this happened....
So => 3 years with no revenue for armor.....execution failure....
Only problem is Sintx armor didnt become operational until Feb 2023 so how could they generate revenue in 2022? Also despite the setback with the furnace, they have successfully tested vehicle & body amror for production. It didnt indicate when that would occur, but by Q4 the new furnance is supposed to be in place.
SINTX Armor is expected to begin production of a competitively priced body- and vehicle-protective armor product that has undergone successful testing.
Source info:
https://stocktwits.com/Tech01/message/579198810
https://ir.sintx.com/news-events/press-releases/detail/214/sintx-technologies-announces-its-new-utah-armor-facility-is
https://ir.sintx.com/news-events/press-releases/detail/233/sintx-technologies-to-explore-strategic-opportunities
========================================
Section 2 - Renaissance Tech holdings prior to Anson/Frigate & Hudson Bay:
In regards to my post about Renaissance Tech shares in before Anson, fintel shows it earliest stake was Q4 '14. It sold that position in Q1 but was back Q2'15.
2015-02-13 13F Renaissance Technologies Llc 13,661
https://fintel.io/so/us/sint?d=2014-12-31
Renaissance Technologies, LLC 458,498 0.36 143,051 Sep 30, 2015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=118775462
========================================
Section 3 - A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Section 4 - Reply to Joev2,
We already knew they needed money and the offering would have to close July/August timeframe to keep operations going. I expected more but then again it makes sense for them to slowly raise the OS as they need to keep the price over $1. Incidentally if Ansons group of funds have been preshorting this they'll have to buy shares off the market to cover as the ATM is direct to market. Good time to run the price up (wishful thinking). OS appears to be around 748k shares now up from 709K post split.
In regards to Mick Wynhoff's company, yet again, you chose a horrible comparison. Its like comparing growing spinach (Mick Wynhoff company) to almond trees (Sintx). Medtech takes alot of capital for R&D, water treatment does not. Very different fields hence youre using growing spinach (how Wynoff managed to avoid toxic financiers like Anson) as an example compared to growing almonds (Develop tech for use in markets that exceed hundreds of billions in size) just doesnt cut it. Spinach is very easy to grow and takes limited investment just so you know. Also who the F would want a water treatment company outside of maybe harvesting some tax loss? How likely is it the Ansons of the world would even want their properitary blend of chemicals for treating pools?
I have SEEN filings with conditions such as a clause stating the lender/ buyer could NOT sell shares for a certain period of time
Ive seen this clause used for Sintx offerings before but doesnt naked shorting and covering those naked shorts with converted warrants circumvent that?
The only evidence I personally need is the stock price as to how the CEO or company is performing.
Thats about the dumbest thing i think you have ever posted Joe. That means when Theranos, or any scam stock is flying high on the markets, its all you need to know about the company. Buys lots of shares of scam stocks being pumped. Come on we both know youre smarter than that. That cant be a honest statement on your part.
TA, you are deceptive as always. I said on June 7th that an offering needed to close July/August timeframe. Just expected a S1 offering instead of part of the shelf offering.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174564223
joev2
2 weeks ago
I had personally spoken to Mick numerous times and he volunteered the info regarding gamers such as Maxim without naming any particular one. I'm only replying as a courtesy because I don't expect you to believe me anyway, and besides it's technically only hearsay. Fact is though, he never did go the route of convertibles and apparently started his tenure with about 30 million outstanding and ended it about 8 years later at 67 million.
As far as what Sonny could do or could have done is simple: do business with a lender that was more favorable to the shareholders. I have SEEN filings with conditions such as a clause stating the lender/ buyer could NOT sell shares for a certain period of time. This clearly prevents the Anson types from taking an advantage, right out the gate. Nothing more to say. I am not going to look for documents all over the place, trying to prove a point to you. It is what it is. Doesn't matter to me whether or not you believe me. I know what I am saying is true and I have no reason to make it up. I'm not trading Sint, shorting it or investing in it. I don't like the company based mostly on management and that hasn't changed for as long as I've been on this board. The only evidence I personally need is the stock price as to how the CEO or company is performing. Only a negative direction continually, tells enough of the story to me....
From another poster on the Pfsd board:
Mick and Mike brought the company to Racine, WI on June 4, 2004. It had 30,299,000 shares outstanding at 6-30-04 FY yearend and had sales of just 61,703 for that year. Mick left in Oct 2011. For the 7 1/4 years he ran the place ending on 9-30-11 shares o/s increased to 67,857,000 and the company lost 2.9 million or an average of 399K per year.
One last thing concerning Pfsd: although the company had sales of 61k in Mick's first year, they ended up with over a million rev per year. Problem with small companies is getting out of the debt hole. However, unlike Sonny, Mick made sure shareholders would not get crushed. Unfortunately with Pfsd as with many others, they just couldn't ever sustain a profit.
boston745
2 weeks ago
Ansons conspiracy of funds couldnt target every company with promising products. It would need to see certain risk reward type scenarios or if its as i suspect, they work as a front for other companies. I havent connected Renaissance to say Hudson Bay for instance, but if there is then Ansons conspiracy of funds could be working for Renaissance and thus in J&J interests. Thats just an example because i read that Ansons was given a small fine to protect some Blue Chip companies of which J&J is definitely one. And Renaissance has been shorting here since before Anson the other family funds showed up.
The minor nature of the infraction and the small size of the settlement was far from the grand hype that surrounded the investigation, which was said to involve dozens of short sellers, and numerous companies, including some blue-chip names. One fund manager called the SEC settlement with Anson “a consolation prize for some ticky tack bullshit.”
Ok. you named dropped Mick Wynoff. Could you give some information how hes relevant to this discussion? Like how he defended his company and protected its shareholders from this conspiracy of funds?
All the evidence against Maxim? There isnt alot of evidence against them but they certainly should have been aware that there was a family of funds connected to Anson fund that work together to manipulate companies like Sintx. As to if Maxim works with them in any capacity, i do not know? They provide placement services as well as market making services. We know they have at least failed to report some of the shit Ansons group of funds do. If theres any impropriety there, i again do not know? Be interested in finding out however. Now that ive disclosed all this is Sonny still working with Maxim? Its Ascendiant Capital that its working with atm. What Sonny does moving forward will give us some clue. However the shelf offering is still registered with Maxim providing placement services for that.
You dont lay any actual evidence down. You merely claim something is this way or that way. Like claiming theres no conspiracy here and using sarcasm to downplay the likelihood that there were any hostile funds trying to takeover Sintx. Post some evidence. Like what could Sonny do to protect Sintx IP and its shareholders at the same time? If you actually gave examples it would show some ineptitude on his part in regards to public markets.
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
joev2
2 weeks ago
What about the evidence that Anson types can't play the same way with every company that has promising products?
What about the evidence that "informed" CEOs (such as Mick Wynhoff) aren't easily played like "uninformed" ones (such as Bal, assuming he is only uninformed) and therefore are able to keep the o/s pretty much at bay, rather than diluting and reversing continually?
What about the evidence that given ALL the information out there concerning Maxim already, Sonny (unlike those who have learned) continues doing business 'as usual' with them, as if nothing is amiss; thereby being the real enabler of the shorts, hedge funds and gamers?
So you claim I use disinformation techniques and I likewise claim, you ignore any evidence that doesn't fit your preconceived narrative.
No need to waste a post replying. According to some, I'm one of the rare ones that bothers reading them anyway. And if true, why would that be, considering the company has been building shareholder value (according to you) while the stock price has gone down from over a million to $5 per share?
boston745
2 weeks ago
You continue to claim things to be one way yet little evidence to support it. Also, you continue to employ disinformation techniques in your posts to try to steer the conversation away from actual evidence. Im sure you'd love it if i spent my limited 3 posts here focused on you or anything else not of relevance.
Keep posting Boston. In this way, you can continue confirming to yourself that you alone, are correct; you alone know the reasons why Sint (with Bal as CEO) is a winner, despite evidence proving otherwise time and time again.
Obviously Anson and that conspiracy of hedgefunds agrees with me that Sintx Si3N4 IP is very valuable which is why they are trying to get the company and continue to attack the stockprice.
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as this group has been after Sintx IP for going on a decade. If this group cannot get the IP through hostile means, its going to limit Sintx ability to raise funds through the marketplace to push them to sell or into bankruptcy. Sonny has successfully employed various means to prevent hostile takeovers so far. Market side is Sintx biggest weakness however and thus it needs one of its major partners like Zimmer Biomet to step up. This is why i believe its exploring its strategic options.
Their playbook is simple: they find a promising company like Nano that has attracted significant investment, furtively acquire a large position, and then seek to dismantle the company and distribute its cash for Defendants’ own benefit.
https://www.sec.gov/Archives/edgar/data/1491072/000119312523131774/d264274dex993.htm
https://fastercapital.com/content/Securities-fraud--How-ShortandDistort-Undermines-Market-Integrity.html#How-ShortandDistort-Schemes-Operate-
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
=======================================
Here are all the anti-takeover provisions employed at Sintx.
1. Poison pill aka Shareholder Rights Plan
2. Staggered Board
3. Shark Repellant - requiring supermajority vote
4. Golden Parachute for management
5. Crown Jewel Defense - CTL has first rights to acquire Sintx IP.
6. CTL is setup as a White Knight via its first rights to acquire Sintx IP.
7. If Sintx sold its main IP to CTL thats effectively scorched earth as Sintx has little value, in comparison, without its patent portfolio. Sintx would still have TA&T & Sintx Armor for value in the event it had to sell its core Si3n4 IP to CTL, even if for a short time.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
joev2
2 weeks ago
The ideologue has once again spoken. Thank you Atlanta, TA and others for often pointing out to me, the fallacies of trying to have a conversation with a self-centered, unrealistic, and unhealthy individual who (for the life of me) is either unable or unwilling to engage in a civil discourse concerning the merits or lack of, regarding a company. Keep posting Boston. In this way, you can continue confirming to yourself that you alone, are correct; you alone know the reasons why Sint (with Bal as CEO) is a winner, despite evidence proving otherwise time and time again. And let's not forget, ANY criticism whatsoever must be deflected as being off-topic, bashing, or any other form of misinformation and disinformation. For as long as Teflon Sonny can remain untouched by criticism in the imagination of the one and only all-knowing one, then he and the company he runs, will remain off limits to the reality of what's ACTUALLY happening. And who cares about those who have been damaged and wrongly influenced (by guess who?) to invest, anyway? After all, there's plenty of blame to go around. Bashers, hedge funds...anyone but Sonny and his idolmaker is at fault.
To others who are trying to understand how Maxim-types get away with the garbage they pull, an unbiased view of how this company goes forth about their so-called 'business operations' day to day, from day one in the public eye, will easily give you the answer. Again, naivety, ignorance, stupidity, and/ or corruption is NO excuse for why a Maxim is allowed to play the games they do. However, leadership is often responsible (as in this case) as to why the Maxim types continue on, unabated. Sonny, continues to do business with them in spite of the sec's findings; continues to do business basically the same exact way, as always with them (no stipulations to protect shareholders in the lending process from having their stock shorted ro death) and continues to reap (and will continue to reap) the same horrific results for shareholders, as the company under Bal, has ALWAYS done.
And finally to Boston: remember to respond by shifting from the simple truths I have presented. After all, as mentioned, ideologues stay the course with only one possible answer: their own. Go for it!
boston745
2 weeks ago
How to Manipulate People-7 Signs of a Con Artist You Need to Know to Avoid Being a Victim
Con artists realize that the beliefs of people are more malleable in a heightened state of emotion.
The Second Phase of a Con Is Establishing the “Villan” and the “Victim.”
Sonny's bloated salary, undeserved bonuses and inexplicable disdain for shareholders who KNOW they have been thoroughly walked over, used, and lied to over and over again (when he's not ignoring them) other than yourself (who alone appears to think he's the greatest of individuals with great altruistic motives), I will continue to call him out.
First Joe creates a heightened state of emotion through declaration that Sonny lives the good life with "undeserved salary and bonuses" while showing complete disdain for shareholder (thats a lie), claiming Sonny has walked over (dont believe so), ignored (lie), and lied to shareholders (most likely true to a degree). Meanwhile Sonny and the board are the villians who have caused shareholders to lose 99% of their shares value. Joe claims this all while being aware theres been a short and distort campaign against SINT to drive the price lower, which he aids with his bashing oriented posts whether intentional or not, being waged against Sintx for most of Sonny's tenure. Hes also aware of the sheer value of the IP and thus value being created for stakeholders on the company side of the coin.
Joe as long as your posts use bashing, conning, & disinformation techniques im going to call you out. All things that are not necessary if you had much in the way of substance.
Source material:
https://fastercapital.com/content/Market-Manipulation--Exposing-the-Tactics-of-Stock-Bashers.html#Common-Tactics-Employed-by-Stock-Bashers
https://www.leadersinstitute.com/how-to-manipulate-people-7-signs-of-a-con-artist-you-need-to-know-to-avoid-being-a-victim/
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4 can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
joev2
2 weeks ago
Once again, you only see what you want to see. Who is benefitting TODAY from Sonny's great work? Unless or UNTIL something actually manifests itself other than Sonny's bloated salary, undeserved bonuses and inexplicable disdain for shareholders who KNOW they have been thoroughly walked over, used, and lied to over and over again (when he's not ignoring them) other than yourself (who alone appears to think he's the greatest of individuals with great altruistic motives), I will continue to call him out. Keep buying! Hopefully, someone with a brain who's curious about Sint, will leave this loser stock alone. Unlike you, I don't waste 14 years expecting things to change when everything always stays the same. Looks like a new pump is starting up. Now there's a positive! Even scammy type companies increase shareholder value now and then.....
Btw, please stop deflecting with the basher crap. Anyone who brings down a stock from a million to $5 deserves to be criticized....even your idol. Stupidity, naivety, or corruption is no excuse and he's STILL doing business with Maxim, which demonstrates at the very least, he doesn't know how to properly run the company.
boston745
2 weeks ago
In your horrible example, and i mean it is horrible, as the two things are not equivalent at all, you actually gave Gacy credit for the good he did while continuing to fail to do so with Sonny (again typical of a stock basher).
The thing with your Gacy scenario is Gacy did way more to damage to society than help. Part of its because youre not factoring the level of psychological harm caused to all those victims family and friends in addition to the lives lost and possible positive impact they may have had. Its unlikely Gacy could ever do enough good for society to offset the damage he did. Incidentally this is part of my argument against Tesla because i believe, based on alot of evidence, that Teslas go out of control/spontaneously combust because of EM radiation. That does psychological harm to all those involved and around them, it results in the deaths of some involved obviously, and it leads to the false conviction of innocents whos only mistake was driving a Tesla or EV. Thus is my opinion that Teslas and EVs will do more harm to society than good which is a large reason why i post there as i have no long or short position. Not that i wouldnt swing trade the stock.
Sonny/Sintx on the otherhand, can not only make stakeholders alot of money, significant ROI, but the products could help tens of millions to hundreds of millions depending on how effective it is as PPE. On top of that most of the societal damage that's been done here is the result of a conspiracy of hedge funds and their short and distort campaign. Not to mention their apparent attempts to try to acquire the tech cheap which has resulted in Sonny employing methods to protect IP. If the hedge funds acquired Sintx and took it private for cheap, it harms some stakeholders more than communal stakeholders unless those hedge funds sold the IP to companies that will sit on the IP instead of commercializing it. Yes some companies will hold patents just to prevent others from bringing tech to market. That would do immeasurable amounts of damage to society.
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
joev2
2 weeks ago
We will never agree. It's really that simple. To me, although it's a poor comparison, this is what came to mind. John Wayne Gacy was a serial killer, preying on young men BUT he brought a lot of happiness to kids, playing a clown; not to mention he was quite an artist!
Still, I can not get passed the fact that he was a serial killer and ALL the good he supposedly did, pales in comparison. He was executed despite the good he brought to others. I say, well deserved!
Now when we look at Sonny, I can't get passed the fact that under his leadership, a 10 million dollar investment a number of years back is worth today, approximately $50. It negates all the potential good in my eyes. NOW, IF this product is EVER sold and USED for all the benefits you and some analyses claim, then there is a possibility I will revamp my views. Right now though, I can't and won't get passed the fact that all shareholders have suffered major losses under Sonny's leadership and he in turn, rewards himself with bonuses for his performance. Talk about a slap in the face.....
boston745
2 weeks ago
Joe you didnt touch on any of the points i listed in my last post, so here it is again.
You see the following about sheer market size and you continue to hammer that Sonny is the problem? Sonny's a big reason why their potential addressable markets is over $320 billion; Sintx addressable market was about $70 billion (Ortho/Dental) when Sonny took over as CEO. As Sonny oversaw development of Si3N4 coating and Si3N4 imbued PEEK, he increased the potential size of the ortho/dental markets that Si3N4 can penetrate.
Usually these types of things warrants praise not ridicule; seriously its one thing to criticize but you gotta recognize whats been achieved as well unless youre a stock basher. In regards to stockprice, you dont agree Sonny should be trying to defend the companies IP from vulture funds? If successful he can make stakeholders alot more money than if he lost and those funds ripped Sintx apart after taking Sintx private for pennies comparatively. Shareholder rights offerings can help protect stakeholders investment during this battle with their full ratchet anti-dilutive protections.
Sonny is stepping down as CEO so this suggests bulk R&D is done, as hes a medical/materials scientist, and its time to get a commercialization oriented CEO. Time to commercialize that IP...way overdue imo. This is where i think the bulk of the legit criticism for Sonny should be, his "snail pace" getting products to market.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4 can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
========================================
A conspiracy of shorting and distorting.
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108
joev2
2 weeks ago
Friend is just a term, not meant to be taken further. I won't use it again with you. As for market manipulation, we all know it is there. In previous posts, I've shown how CEOs can to some degree, thwart the gamers. One method is putting stipulations on a loan that doesn't allow for shorting or selling shares for a certain amount of time. Companies like Maxim have always taken advantage of the gullible and uninformed. I mentioned Pfsd in their earlier days and how the CEO recognized the games from lenders like Maxim, and being aware, he was able to keep the o/s under 100 million for years! No reverse splits either.
There are many to blame for poor investment decisions. First off, we need to be aware. Second, the SEC should be more pro-active. Third, the CEO needs to have a clue as to what he's getting into. Sonny wasn't the first and certainly won't be the last sucker to get taken. I'm assuming for the sake of argument, that he didn't know what he was doing, as opposed to being part of the game plan.
boston745
2 weeks ago
You see the following about sheer market size and you continue to hammer that Sonny is the problem? Sonny's a big reason why their potential addressable markets is over $320 billion. Usually that warrants praise not ridicule; seriously its one thing to criticize but you gotta recognize achievements too. In regards to stockprice, you dont agree Sonny should be trying to defend the companies IP from vulture funds? If successful he can make stakeholders alot more money than if he lost and those funds ripped Sintx apart after taking Sintx private for pennies comparatively.
Sonny is stepping down as CEO so this suggests bulk R&D is done, as hes a scientist, and its time to get a commercialization oriented CEO. Time to commercialize that IP...way overdue imo.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4 can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
boston745
2 weeks ago
According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. IP thats destined to take over the ortho industry according to one study linked at the bottom of this post.
Their playbook is simple: they find a promising company like Nano that has attracted significant investment, furtively acquire a large position, and then seek to dismantle the company and distribute its cash for Defendants’ own benefit.
https://www.sec.gov/Archives/edgar/data/1491072/000119312523131774/d264274dex993.htm
So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed. A work in progress.
Transitive Property:
In 2003, Zimmer acquired a materials company for $232m with $108m of it upfront and the remaining $124m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabecular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee. That said, Trabecular metal cannot be used as a coating or imbued in materials like silicon nitride can to bring those materials its beneficial enhancements. Thus its market potential in the ortho/dental markets was smaller.
Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m
Accumulated Deficit and Tax Write-off
Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Also, acquiring Sintx for that amount would increase goodwill which is an asset the acquiring company can depreciate and thus provide additional tax benefit as well as increase its assets.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4 can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.
In Summary, you can see that Sintx has extremely valuable IP that can be used in markets that are cumulatively in the hundreds of billions in size. That is why Anson and the other family of funds its connected to would want to get their hands onto that IP. Like Nano, it looks like this conspiracy of funds was getting ready to make a move before I exposed them with three of the funds accumulating a position this year. However recent offerings by management seems to have helped in diluting their positions to prevent a similar situation to Nano as shown in the first of these three posts.
Because Sonny has employed several methods of protection to protect Sintx IP from hostile entities, their only option to get the IP is hope they can drive Sintx into bankruptcy as Sonny has setup crown jewels defense in the event this group attempts a hostile takeover. As Sintx has no debt, Sonny and then board cannot be forced into selling the IP to a particular entity. Upside to Sintx not having loans and likely a big reason it has not obtained one so since Hercules loan in 2014.
4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
https://www.sec.gov/Archives/edgar/data/1269026/000107997324000472/0001079973-24-000472-index.htm
Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.
(2) Based on 51,080,139 shares of Common Stock outstanding as reported in the Issuer’s filings with the Securities and Exchange Commission.
Once this offering completed, L1 stake in Sintx became 3.6%.
This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position (Poison Pill type offering?). Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds as well as raising needed funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. This has likely prompted the recent new of Sintx exploring strategic opportunities.
=======================================
Here are all the anti-takeover provisions employed at Sintx.
1. Poison pill aka Shareholder Rights Plan
2. Staggered Board
3. Shark Repellant - requiring supermajority vote
4. Golden Parachute for management
5. Crown Jewel Defense - CTL has first rights to acquire Sintx IP.
6. CTL is setup as a White Knight via its first rights to acquire Sintx IP.
7. If Sintx sold its main IP to CTL thats effectively scorched earth as Sintx has little value, in comparison, without its patent portfolio. Sintx would still have TA&T & Sintx Armor for value in the event it had to sell its core Si3n4 IP to CTL, even if for a short time.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Joe, its not slander. Your posts are constantly negative which is hallmark of a stock basher and thus is more evidence than anything you have ever shown to the corruption of management. Your posts indicate your in league with the short and distort campaign being waged by the conspiracy of funds.
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments. For example, if you come across an individual who consistently posts negative comments about a company's financials without acknowledging any positive growth or potential opportunities, it could be a red flag.
Thats what you have done in your posts, exaggerate negatives and ignore/downplay positives.
https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html#Signs-to-Look-Out-For
joev2
2 weeks ago
I put the question marks in my message for a reason. Of course I have no proof, but I also can tell when a stock has major issues (something Sint has had since day one). All things considered, I, like you, conjecture as to why a stock performs the way it does. Unlike your conjecturing about say, Tsla, my conjecturing of concern, should be noted, based on the stock's continuing miserable performance; whereas your conjecturing on Tsla apparently has LITTLE or NO merit based on the stock's continual positive performance, funds and insiders partaking (the opposite of Sint) etc. And let's not forget to mention, Musk's apparent openness to analysts, national interviews and so on, in contrast to Sonny's continuing secretiveness, as evidenced by closed cc's etc, with the exception of a ton of patents (for what, I've yet to find out).
boston745
2 weeks ago
Maxim Investors, an interesting title for this group which it aided Arch Therapeutics with the placement.
proceeds of approximately $3,390,600 in the aggregate, of which approximately $2,084,000 was attributable to the Maxim Investors.
The Investors included Anson Investments Master Fund LP (“Anson”), Karen Carlin, P. Timothy Connolly, CVI Investments, Inc. (“CVI”), Drake Partners Equity LLC (“Drake”), Empery Asset Master, Ltd, Empery Tax Efficient II, LP, Empery Tax Efficient, LP, Jonathan Galli, Vikas Gulati and Mirella Gulati, Hudson Bay Master Fund Ltd., Intracoastal Capital, LLC (“Intracoastal”), Keyes Sulat Revocable Trust (the “Trust”), Lorraine A. Malanga, James M. McKeone, IRA FBO Ana B Parker (“Ms. Parker”), Dr. Stephanie Plent, and Popham Management, LLC (“Popham”). Anson, Intracoastal, and CVI or their respective affiliates, were investors in the Company’s 2014 Private Placement Financing that concluded on February 4, 2014
Conspiracy of funds Maxim tapped for this offering. I find it hard to believe Maxim did not know these funds worked together:
Anson
CVI
Empery Assets
Hudson Bay
Intracoastal
Maxim Group parent company under fire for alleged sanctions busting, money laundering
Kazakhstan and New York-based Freedom Holdings denies charges from activist short-selling fund Hindenberg Research
The new owner of New York-based investment bank the Maxim Group — which has been controversial for its deal-making practices in shipping — is now fending off explosive allegations over its own activities.
Kazakhstan and New York-based Freedom Holding Corp (FHC) — a $4.6bn online brokerage founded in Moscow — has been accused of money laundering and helping Russian oligarchs evade sanctions over the war in Ukraine.
Sort of goes with its sanctions over failing to report transactions which could be cover for money laundering. That said, FHC and Maxim cancelled this acquisition agreement so it looks like tradewinds article jumped the gun calling FHC its parent company. Maybe the deal was cancelled, in part, because of this accusation?
Freedom Holding Corp. cancelled the acquisition of Maxim Group LLC from MJR Holdings Inc. on October 31, 2023. Freedom Holding Corp., Maxim Partners LLC and MJR Holdings, Inc. determined that the conditions to closing set out in the Purchase Agreement will not be fulfilled by December 31, 2023, accordingly, the parties have mutually terminated the transaction.
Quote Sources:
https://ir.archtherapeutics.com/all-sec-filings/content/0001144204-16-106488/v441469_8k.htm
https://www.tradewindsnews.com/finance/maxim-group-parent-company-under-fire-for-alleged-sanctions-busting-money-laundering/2-1-1504201
https://www.marketscreener.com/quote/stock/FREEDOM-HOLDING-CORP-13908408/news/Freedom-Holding-Corp-cancelled-the-acquisition-of-Maxim-Group-LLC-from-MJR-Holdings-Inc-45273337/
boston745
2 weeks ago
SEC Charges Maxim with Failing to File Suspicious Activity Reports and Violations of Regulation SHO
According to the SEC’s order, from at least January 2018 through January 2019, Maxim facilitated order flow from other broker-dealers engaged in the sale of large volumes of shares of low-priced over-the-counter microcap securities but did not adequately design or implement its anti-money laundering policies and procedures so as to reasonably address the risks associated with this business. The order further finds that due to these deficiencies, and Maxim’s failure to sufficiently investigate red flags, Maxim failed to file SARs for numerous suspicious transactions.
Also, according to the order, Maxim routinely facilitated “not held” long sale orders in low-priced securities from its broker-dealer customers by executing a series of principal short sales throughout the day and covering its short positions by purchasing the stock from the broker-dealer customer at a lower price. The order finds that Maxim did not, however, “locate” shares of the stock to borrow prior to effecting its short sales as required by the short-selling provisions of Regulation SHO.
I wonder if Maxim works with hedge funds like conspiracy of hedge funds or simply turns a blind eye?
I do recall someone mentioning money laundering in connections with these hedge funds.
https://www.sec.gov/enforcement-litigation/administrative-proceedings/34-98605-s
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
XenaLives
2 weeks ago
Hot Features
Premium
